the coronavirus then feel free to write to us on how you treat channel science correspondent derrick williams will look into the. what impact on national health will reopening schools have at this stage of the pandemic . i've been sitting on this divisive question for a while to watch how things develop as kids in many countries in the northern hemisphere including my own returned to schools schools can act as super spreaders sites and with classrooms being closed areas where lots of kids gather for extended periods of time you'd have expected to see spikes in cases within societies as a whole in the few weeks after they reopened a couple of months ago but a lot of current data indicates that didn't happen numbers of cases in both the u.s. and europe have of course risen dramatically since then but many experts believe that isn't down to reopen schools but to other factors a number of studies from different countries including ones that collect extensive contact tracing information they're painting the picture that although kids can of course catch the virus and of course they can give it to

so now let's put one of them to ask science correspondent, derrick williams. should people who have already had coded 1000 continue to wear masks? i answered this question a few months ago and the guidelines haven't really changed, but it gets sent in so often that i guess it's, it's maybe time for a reminder. the short answer is that a lot of aspects of covert 19 immunity are still pretty hazy because people simply haven't been recovering from it long enough to provide solid, long term data. based on what we've seen so far with the disease. people who get infected once do acquire some immunity for a period of time. the big problem is, we still don't really know how long on average that period is. so for some framework, it makes sense to look at what we know about other corona viruses that infect humans and, and studies there have revealed that immunity can wane pretty swiftly. a number of them convincingly show people can be really infected with some of those pathogens within a year of catching them once so far, there have been a few dozen documented cases of

my pleasure and time for your questions on the coronavirus is derrick williams. what are the differences and similarities between flu and covert 19? this is a regular question now that flu season is upon us in the northern hemisphere. let's, let's look at the similarities between the 2 diseases 1st starting with how they spread. which for both is mainly through droplets emitted when infected people cough or sneeze or talk with both respiratory diseases. people are also contagious before they begin to show symptoms themselves. and both can also have the same general pathology, at least at 1st. so many of the same symptoms, according to the u.s. centers for disease control, the overlap includes fever, cough, shortness of breath, the teague sore throats, runny nose, muscle pain, and headache. so if you develop those symptoms, especially in combination, it's a good idea to get tested. finally, of course, both can kill you, but that brings me to the 1st of the big differences i want to mention. covert 19 is a lot more likely to kill you than the flu, especially if you

so now let's put one of them to ask science correspondent, derrick williams. should people who have already had coded 1000 continue to wear masks? i answered this question a few months ago and the guidelines haven't really changed, but it gets sent in so often that i guess it's, it's maybe time for a reminder. the short answer is that a lot of aspects of covert 19 immunity are still pretty hazy because people simply haven't been recovering from it long enough to provide solid, long term data. based on what we've seen so far with the disease. people who get infected once do acquire some immunity for a period of time. the big problem is, we still don't really know how long on average that period is. so for some framework, it makes sense to look at what we know about other corona viruses that infect humans and, and studies there, have revealed that immunity can wane pretty swiftly. a number of them convincingly show people can be re infected with some of those pathogens within a year of catching them once so far, there have been a few dozen documented cases of th

very good advice your questions now on the coronavirus is the science correspondent derrick williams . i'm curious about differences in covert 19 infection rates seen in primary versus secondary schools are there studies on that. there's a real jungle of conflicting data on this topic and pretty much any other question that you can think of that's related to kids and this pandemic so so let's start with what seems at least mostly clear at this point 1st several studies including a few big ones have shown pretty convincingly that infected kids can also transmit the virus to others but the data also looks pretty strong that a kids are more likely to get it from adults than the other way around and b. that smaller children in particular so those under 12 or so are a lot less likely to transmit it to others than older children or adults the european center for disease prevention and control has emphasized that unlike with other respiratory diseases there is no evidence that kids are primary drivers of covert 19 outbreaks one of the big problems with trying to compare a primary to seconda

finally, your questions is our science correspondent, derrick williams, by on tack. and pfizer have developed a vaccine to provide coverage 19. are there pharmaceutical companies also working on therapies to cure patients who already have it? as we'll celebrate very promising interim vaccine candidate results and look forward to possible breakthroughs with others soon. it's kind of easy to ignore the elephant in the room, which is that covert 19 is going to make this winter in the northern hemisphere long, hard and likely very grim, even in a perfect world with a vaccine approved by the end of november. it will take many more months if not years to distribute it. and although doctors have gotten better at treating patients, thereby improving survival rates, we still don't have really effective drugs to treat those who become ill or who become very ill. in fact, a major disputed pre-print study released by the w.h.o. last month. more or less said that most of what's in our medicine cabinet now, that can be produced at a large scale, basically doesn't really work. so w

my pleasure and time for your questions on the coronavirus is derrick williams. what are the differences and similarities between flu and covert 19? this is a regular question now that flu season is upon us in the northern hemisphere. but let's look at the similarities between the 2 diseases 1st starting with how they spread. which for both is mainly through droplets emitted when infected people cough or sneeze or talk with both respiratory diseases. people are also contagious before they begin to show symptoms themselves. and both can also have the same general path ology, at least at 1st. so many of the same symptoms, according to the u.s. centers for disease control, the overlap includes fever,, cough, shortness of breath, the t., sore throat, runny nose, muscle pain, and headache. so if you develop those symptoms, especially in combination, it's a good idea to get tested. finally, of course, both can kill you, but that brings me to the 1st of the big differences i want to mention. coated 19 is a lot more likely to kill you than the flu, especially if you're e

one of your questions submitted through how you cheat channel to our science correspondent, derrick williams. i would like to know why the pfizer vaccine needs to be kept. so very cold, especially since it presumably has to be warmed up prior to administrative. to answer this, i 1st have to go over a few basics of cell biology. the vaccine developed by biotech and pfizer is what's known as a messenger r.n.a. or m r n a backseat l m r n a is a chain like molecule that fulfills a very important function and cells that it contains codes to make proteins and it acts as a messenger between the cells control center and its protein building machinery as hence the name. but the protein, this particular m r n a vaccine that codes for isn't a human one. it's a protein that's made by the corona virus. and when the m.r. n a is injected, it causes your cells to begin making that viral protein, and that provokes an immune response, just as if you caught coke at 19, sending in the pretty simple quick to produce more of a code molecules to make these, these complicated proteins and getting the body to do al

put one of your questions submitted through how you chip channel to our science correspondent, derrick williams. i would like to know why the pfizer vaccine needs to be kept. so very cold, especially since it presumably has to be warmed up prior to administer a should. to answer this, i 1st have to go over a few basics of cell biology. the vaccine developed by biotech and pfizer is what's known as a messenger r.n.a. or m r n a backseat l m r n a is a chain like molecule that fulfills a very important function and cells. it contains codes to make proteins and it acts as a messenger between the cells control center and its protein building machinery as hence the name. but the protein, this particular m r n a vaccine that codes for isn't a human one. it's a protein that's made by the corona virus, and when the m.r. n a is injected, it causes your cells to begin making that viral protein. and that provokes an immune response, just as if you caught coke at 19, sending in the pretty simple quick to produce more in a code molecules to make these, these complicated proteins and getting the body to do a

put one of your questions submitted through how you chip channel to our science correspondent, derrick williams. i would like to know why the pfizer vaccine needs to be kept. so very cold, especially since it presumably has to be warmed up prior to administrative. to answer this i 1st have to go over a few basics of cell biology. the vaccine developed by biotech and pfizer is what's known as a messenger r.n.a. or m r n a backseat l m r n a is a chain like molecule that fulfills a very important function and cells. it contains codes to make proteins and it acts as a messenger between the cells control center and its protein building machinery as hence the name. but the protein, this particular m r n a vaccine that codes for isn't a human one. it's a protein that's made by the corona virus, and when the m.r. n a is injected, it causes your cells to begin making that viral protein. and that provokes an immune response, just as if you caught coke at 19, sending in the pretty simple quick to produce more in a code molecules to make these, these complicated proteins and getting the body to do all of

finally, your questions is our science correspondent, derrick williams, by on tack. and pfizer have developed a vaccine to prevent covert 19, are there pharmaceutical companies also working on therapies to cure patients who already have it? has wheels eyes or have developed a vaccine to prevent covert 19, are there pharmaceutical companies also working on therapies to cure patients who already have it? as we'll celebrate very promising interim vaccine candidate results and look forward to possible breakthroughs with others soon. it's kind of easy to ignore the elephant in the room, which is that covert 19 is going to make this winter in the northern hemisphere long, hard and likely very grim, even in a perfect world with a vaccine approved by the end of november. it will take many more months if not years to distribute it. and although doctors have gotten better at treating patients, thereby improving survival rates, we still don't have really effective drugs to treat those who become ill or who become very ill. in fact, a major disputed pre-print study released by t

robert time nightgowns or one of your questions over to our science correspondent, derrick williams. how long does it typically take in europe to approve a vaccine after phase 3, trial results are published under ordinary circumstances, not in the midst of a public health emergency. the scientific evaluation carried out after phase 3 trials by the e. m. a. the european medicines agency, it takes time developers 1st, have to submit testing data, and what's called a marketing authorization application that governs general approvals for medicinal products. throughout the e.u. . a board at the agency called the committee for medicinal products for human use is required to submit a scientific verdict on the application within $210.00 days. it then passes that opinion on to the european commission, which makes a decision on whether or not to grant an approval within $67.00 more days. so all in all the process can take between 9 and 10 months. but that's under ordinary circumstances. in the midst of this pandemic, the e m a has set up a special task force to help fast track covert 19 treatm

now to answer one of your questions over to our science correspondent, derrick williams. how long does it typically take in europe to approve a vaccine? after phase 3, trial results are published verities under ordinary circumstances, not in the midst of a public health emergency. the scientific evaluation carried out after phase 3 trials by the e. m. a. the european medicines agency, it takes time developers 1st, have to submit testing data, and what's called a marketing authorization application that governs general approvals for medicinal products. throughout the e.u. . a board at the agency called the committee for medicinal products for human use is required to submit a scientific verdict on the application within $210.00 days. it then passes that opinion on to the european commission, which makes a decision on whether or not to grant an approval within $67.00 more days. so all in all the process can take between 9 and 10 months. but that's under ordinary circumstances. in the midst of this pandemic, the e m a has set up a special task force to help fast track covert

coronavirus then feel free to write to us on our you tube channel the science correspondent derrick williams will look into the. what impact on national health will reopening schools have at this stage of the pandemic . i've been sitting on this divisive question for a while to watch how things develop as kids in many countries in the northern hemisphere including my own returned to schools schools can act as super spreaders sites and with classrooms being closed areas where lots of kids gather for extended periods of time you'd have expected to see spikes in cases within societies as a whole in the few weeks after they reopened a couple of months ago but a lot of current data indicates that didn't happen numbers of cases in both the u.s. and europe have of course risen dramatically since then but many experts believe that isn't down to reopen schools but to other factors a number of studies from different countries including ones that collect extensive contact tracing information they're painting the picture that although kids can of course catch the virus and of course they can give it to

finally, your questions is our science correspondent, derrick williams, by on track and pfizer have developed a vaccine to prevent covert 19. are there pharmaceutical companies also working on therapies to cure patients who already have it? as we all celebrate very promising interim that seem candid, it results and look forward to possible breakthroughs with others soon. it's kind of easy to ignore the elephant in the room, which is that covert 19 is going to make this winter in the northern hemisphere long, hard and likely very grim, even in a perfect world with a vaccine approved by the end of november. it will take many more months if not years to distribute it. and although doctors have gotten better at treating patients, thereby improving survival rates, we still don't have really effective drugs to treat those who become ill or who become very ill. in fact, a major disputed pre-print study released by the w.h.o. last month. more or less said that most of what's in our medicine cabinet now, that can be produced at a large scale, basically doesn't really work. so why don't we have more co

very good advice your questions now on the coronavirus is the science correspondent derrick williams . i'm curious about differences in covert 19 infection rates seen in primary versus secondary schools are there studies on that. there's a real jungle of conflicting data on this topic and pretty much any other question that you can think of that's related to kids and this pandemic so so let's start with what seems at least mostly clear at this point 1st several studies including a few big ones have shown pretty convincingly that infected kids can also transmit the virus to others but the data also looks pretty strong that a kids are more likely to get it from adults than the other way around and b. that smaller children in particular so those under 12 or so are a lot less likely to transmit it to others than older children or adults the european center for disease prevention and control has emphasized that unlike with other respiratory diseases there is no evidence that kids are primary drivers of covert 19 outbreaks one of the big problems with trying to compare a primary to seconda

coronavirus then feel free to write to us on our you tube channel to tell you science correspondent derrick williams will look into the. what impact on national health will reopening schools have at this stage of the pandemic . i've been sitting on this divisive question for a while to watch how things develop as kids in many countries in the northern hemisphere including my own returned to schools schools can act as super spreaders sites and with classrooms being closed areas where there are lots of kids gather for extended periods of time you would have expected to see spikes in cases within societies as a whole in the few weeks after they reopened a couple of months ago but a lot of current data indicates that didn't happen numbers of cases in both the u.s. and europe have of course risen dramatically since then but many experts believe that isn't down to reopen schools but to other factors a number of studies from different countries including ones that collect extensive contact tracing information they are painting the picture that although kids can of course catch the virus and of course they

so now let's put one of them to ask science correspondent, derrick williams. should people who have already had coded 1000 continue to wear masks? i answered this question a few months ago and the guidelines haven't really changed, but it gets sent in so often that i guess it's, it's maybe time for a reminder. the short answer is that a lot of aspects of covert 19 immunity are still pretty hazy because people simply haven't been recovering from it long enough to provide solid, long term data. based on what we've seen so far with the disease. people who get infected once do acquire some immunity for a period of time. the big problem is, we still don't really know how long on average that period is. so for some framework, it makes sense to look at what we know about other corona viruses that infect humans and, and studies there, have revealed that immunity can wane pretty swiftly. a number of them convincingly show people can be really infected with some of those pathogens within a year of catching them once so far, there have been a few dozen documented cases o

put one of your questions submitted through how you chip channel to our science correspondent, derrick williams. i would like to know why the pfizer vaccine needs to be kept. so very cold, especially since it presumably has to be warmed up prior to administer a sion to answer this i 1st have to go over a few basics of cell biology. the vaccine developed by a biotech and pfizer is what's known as a messenger r.n.a. or m r n a vaccine m r n a is a chain like a molecule that fulfills a very important function and cells that it contains codes to make proteins and it acts as a messenger between the cells control center and its protein building machinery as hence the name. but the protein, this particular m r n a vaccine that codes for isn't a human one. it's a protein that's made by the corona virus. and when the m.r. n a is injected, it causes your cells to begin making that viral protein, and that provokes an immune response, just as if you caught coke at 19, sending in the pretty simple quick to produce more of a code molecules to make these, these complicated proteins and getting the body to do

and time for your questions on the coronavirus is derrick williams. what are the differences and similarities between flu and covert 19? this is a regular question now that flu season is upon us in the northern hemisphere. let's, let's look at the similarities between the 2 diseases 1st starting with how they spread. which for both is mainly through droplets emitted when infected people cough or sneeze or talk with both respiratory diseases. people are also contagious before they begin to show symptoms themselves. and both can also have the same general pathology, at least at 1st. so many of the same symptoms, according to the u.s. centers for disease control, the overlap includes fever, cough, shortness of breath, the teague sore throats, runny nose, muscle pain, and headache. so if you develop those symptoms, especially in combination, it's a good idea to get tested. finally, of course, both can kill you, but that brings me to the 1st of the big differences i want to mention. coated 19 is a lot more likely to kill you than the flu, especially if you

so now let's put one of them to ask science correspondent, derrick williams. should people who have already had 1000 continue to wear masks? i answered this question a few months ago in the guidelines haven't really changed, but it gets sent in so often that i guess it's, it's maybe time for a reminder. the short answer is that a lot of aspects of covert 19 immunity are still pretty hazy because people simply haven't been recovering from it long enough to provide solid, long term data. based on what we've seen so far with the disease. people who get infected once do acquire some immunity for a period of time. the big problem is, we still don't really know how long on average that period is. so for some framework, it makes sense to look at what we know about other corona viruses that infect humans and, and studies there, have revealed that immunity can wane pretty swiftly. a number of them convincingly show people can be really infected with some of those pathogens within a year of catching them once so far. there have been a few dozen documented cases of that

finally, your questions is our science correspondent, derrick williams, by on track and pfizer have developed a vaccine to prevent covert 19. are there pharmaceutical companies also working on therapies to cure patients who already have it? as we'll celebrate very promising interim vaccine candidate results and look forward to possible breakthroughs with others soon. it's kind of easy to ignore the elephant in the room, which is that covert 19 is going to make this winter in the northern hemisphere of long, hard and likely very grim, even in a perfect world with a vaccine approved by the end of november. it will take many more months if not years to distribute it. and although doctors have gotten better at treating patients, thereby improving survival rates, we still don't have really effective drugs to treat those who become ill or who become very ill. in fact, a major disputed pre-print study released by the w.h.o. last month. more or less said that most of what's in our medicine cabinet now, that can be produced at a large scale, basically doesn't really work. so why don't we have more com

derrick williams, there i've been physical and that rubs up a full week of coverage on a possible vaccine. also the week that we saw the 1st big breakthrough in developing one for any other developments on the virus go to our web site, e, w dot com slash code 90. about the book's called one click and suddenly there's light. all of india's religions are connected to the power grid, but that still does not guarantee electricity. this summer lamp can close the gap and lighting up life. it seems on every roof is affordable. housing. in order for it to go into the 30 minutes, i'm on t.w. belonging to an official estimates more than 1200000, venezuelans live in colombia, legally, and illegally. already i call them why we're trying to pass way law to visit friends just i don't think i'd ever go back there to live. you know, when i lived there again, i don't know. so i'm not sure bearing witness. global news that matters. the dog made for minds of the one out of 8 people suffering from hunger. the world called program is fighting hunger. join the fight in the height of climate change conference.

robin time nightgowns or one of your questions over to our science correspondent, derrick williams. how long does it typically take in europe to approve a vaccine after phase 3, trial results are published under ordinary circumstances, not in the midst of a public health emergency. the scientific evaluation carried out after phase 3 trials by the e. m. a. the european medicines agency, it takes time developers 1st, have to submit testing data, and what's called a marketing authorization application that governs general approvals for medicinal products. throughout the e.u. . a board at the agency called the committee for medicinal products for human use is required to submit a scientific verdict on the application within $210.00 days. it then passes that opinion on to the european commission, which makes a decision on whether or not to grant an approval within $67.00 more days. so all in all the process can take between 9 and 10 months. but that's under ordinary circumstances. in the midst of this pandemic, the e m a has set up a special task force to help fast track covert 19 treatm

and time for your questions on the coronavirus is derrick williams. what are the differences and similarities between flu and covert 19? this is a regular question now that flu season is upon us in the northern hemisphere. let's, let's look at the similarities between the 2 diseases 1st starting with how they spread, which for both is mainly through droplets emitted when infected people cough or sneeze or talk with both respiratory diseases. people are also contagious before they begin to show symptoms themselves. and both can also have the same general pathology, at least at 1st, so many of the same symptoms. according to the u.s. centers for disease control, the overlap includes fever, cough,, shortness of breath, the t., sore throats, runny nose, muscle pain, and headache. so if you develop those symptoms, especially in combination, it's a good idea to get tested. finally, of course, both can kill you. but that brings me to the 1st of the big differences i want to mention. kogut 19 is a lot more likely to kill you than the flu, especially if you're

my pleasure and time for your questions on the coronavirus is derrick williams. what are the differences and similarities between flu and covert 19? this is a regular question now that flu season is upon us in the northern hemisphere. let's, let's look at the similarities between the 2 diseases 1st starting with how they spread. which for both is mainly through droplets emitted when infected people cough or sneeze or talk with both respiratory diseases. people are also contagious before they begin to show symptoms themselves. and both can also have the same general path ology, at least at 1st. so many of the same symptoms, according to the u.s. centers for disease control, the overlap includes fever,, cough, shortness of breath, the t., sore throats, runny nose, muscle pain, and headache. so if you develop those symptoms, especially in combination, it's a good idea to get tested. finally, of course, both can kill you, but that brings me to the 1st of the big differences i want to mention. kogut 19 is a lot more likely to kill you than the flu, especially if you'r

science correspondent derrick williams will look into them. what impact on national health will reopening schools have at this stage of the pandemic. i've been sitting on this divisive question for a while to watch how things develop as kids in many countries in the northern hemisphere including my own returned to schools is schools can act as super spreaders sites and with classrooms being closed to areas where the lots of kids gather for extended periods of time you'd have expected to see spikes in cases within societies as a whole in the few weeks after they reopened a couple of months ago but a lot of current data indicates that didn't happen numbers of cases in both the us and europe have of course risen dramatically since then but many experts believe that isn't down to reopen schools but to other factors a number of studies from different countries including ones that collect extensive contact tracing information they're painting the picture that although kids can of course catch the virus and of course they can give it to others they d

put one of your questions submitted through how you chip channel to our science correspondent, derrick williams. i would like to know why the pfizer vaccine needs to be kept. so very cold, especially since it presumably has to be warmed up prior to administer a sion to answer this i 1st have to go over a few basics of cell biology. the vaccine developed by biotech and pfizer is what's known as a messenger r.n.a. or m r n a vaccine m r n a is a chain like a molecule that fulfills a very important function and cells that it contains codes to make proteins and it acts as a messenger between the cells control center and its protein building machinery as hence the name. but the protein, this particular m r n a vaccine that codes for isn't a human one. it's a protein that's made by the corona virus. and when the m r n a is injected, it causes your cells to begin making that viral protein, and that provokes an immune response, just as if you caught covert 19 sending in the pretty simple quick to produce more of a code molecules to make these, these complicated proteins and getting the body to do all o